E2777

Monoclonal Anti-c-erbB-2 antibody produced in mouse

~2 mg/mL, clone HER2-96, purified immunoglobulin, buffered aqueous solution

• Synonym(s): Anti-HER-2
• UNSPSC Code: 51111800
• NACRES: NA.41
• MDL number: MFCD00239647
• Conjugate: unconjugated
• Clone: HER2-96, monoclonal
• Application: ARR, ELISA (i), IP
• Citations: 5

Properties

• biological source: mouse
• Quality Level: 200
• conjugate: unconjugated
• antibody form: purified immunoglobulin
• antibody product type: primary antibodies
• clone: HER2-96, monoclonal
• form: buffered aqueous solution
• mol wt: antigen 185 kDa (complete protein), antigen 97-115 kDa (extracellular ligand-binding domain)
• species reactivity: human
• concentration: ~2 mg/mL

Description

General description

Monoclonal Anti-c-erbB-2 (HER-2, Neu) (mouse IgG1 isotype) is derived from the (human epidermal growth factor receptor 2) HER2-96 hybridoma produced by the fusion of mouse myeloma cells and splenocytes from a BALB/c mouse immunized with a purified extracellular domain of human erbB-2, from transfected cells. The human erbB-2 oncogen (also known as HER2, HER-2 or neu) encodes a transmembrane growth factor orphan receptor with a M.W. of 185 kDa (p185). The complete protein consists of an internal cytoplasmic structure with tyrosine kinase activity, a short hydrophobic transmembrane section and an extracellular ligand-binding domain (ECD).

Immunogen

purified extracellular domain of human erbB-2 from transfected cells.

Application

Monoclonal Anti-c-erbB-2 antibody produced in mouse has been used in :

• enzyme linked immunosorbent assay (ELISA)
• immunoprecipitation
• immunohistochemistry
• studies on receptor internalization, phosphorylation, ligand binding and tumor growth inhibition

Biochem/physiol Actions

Erb-b2 receptor tyrosine kinase 2 (ErbB-2) has a pivotal role in signal transduction, where it can stimulate the signal even in the absence of ligand by forming heterodimers with erbB-1/EGF-R, erbB-3, and erbB-4 and hence can modifies ligand affinity. Thus, erbB-2 alters the intracellular responses elicited by EGF and NDF. This control is due to the fact that erbB-2, when in complex with another erbB family receptor, decelerates the rate of ligand dissociation. Therefore, erbB-2 may act as a signalling subunit for other receptors rather than a true growth factor receptor. Because overexpression of the erbB-2 proto-oncogene is frequently associated with an aggressive clinical course of certain human adenocarcinomas, the encoded protein is an attractive target for immunotherapy. Indeed, antibodies to erbB-2 were found to block the crosstalk with growth factor receptors. In addition, receptor overexpression is considered a predictor of poor survival and short time of relapse.

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Safety Information

• Storage Class: 10 - Combustible liquids
• wgk: WGK 2
• flash_point_f: Not applicable
• flash_point_c: Not applicable